Allianz Asset Management’s Roivant Sciences ROIV Stock Holding History

Allianz Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.99M	Sell	56,275 -12,978	-19%	-$384K	﹤0.01%	1731
2026 Q1	$1.92M	Sell	69,253 -16,713	-19%	-$429K	﹤0.01%	1568
2025 Q4	$1.87M	Buy	85,966 +68,742	+399%	+$1.36M	﹤0.01%	1569
2025 Q3	$261K	Buy	+17,224	New	+$213K	﹤0.01%	1930
2024 Q2	–	Sell	-17,900	Closed	-$189K	–	2235
2024 Q1	$189K	Sell	17,900 -48,200	-73%	-$520K	﹤0.01%	1854
2023 Q4	$742K	Hold	66,100	–	–	﹤0.01%	1724
2023 Q3	$772K	Buy	66,100 +46,300	+234%	+$523K	﹤0.01%	1789
2023 Q2	$200	Hold	19,800	–	–	﹤0.01%	2118
2023 Q1	$146K	Buy	+19,800	New	+$163K	﹤0.01%	2053

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Allianz Asset Management's ROIV Position: Q2 2026 in Review

Allianz Asset Management reduced its Roivant Sciences (ROIV) stake by 19% in Q2 2026, selling an estimated $384K and leaving 56,275 shares worth $1.99M. The position accounts for ﹤0.01% of the portfolio, ranked #1731.

Allianz Asset Management first reported a position in ROIV in Q1 2023 and has held it in 9 quarters since. 500 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Allianz Asset Management held 56,275 shares of Roivant Sciences worth $1.99M as of Q2 2026.
Allianz Asset Management sold 12,978 Roivant Sciences shares in Q2 2026, an estimated $384K.
Roivant Sciences made up ﹤0.01% of Allianz Asset Management's portfolio in Q2 2026, its #1731 holding.
Allianz Asset Management first reported a position in Roivant Sciences in Q1 2023 and has held it in 9 quarters since.
500 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Allianz Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.